Groeger et al.39 when using 1 × 1010 CFU viable Bifidobacterium infantis 35624 in the treatment of gastrointestinal and non-gastrointestinal inflammatory disorders, concluded that this strain reduced the levels of C-reactive protein and TNF-α, but had no impact on ulcerative colitis. Here, CRP is linked to ulcerative colitis.